Compiling Pre-DSHEA Ingredient List Relies On Bridging FDA-Industry Gap

FDA and dietary supplement industry stakeholders aren't on the same page about compiling an authoritative list of dietary ingredients that were eligible for use in supplements when Congress established the regulatory framework for the industry, comments at an Oct. 3 public meeting indicate.

Representatives of industry trade groups and other stakeholders recommend that FDA set a reasonable threshold for evidence that verifies a dietary ingredient was available in the US before Congress passed the Dietary Supplement Health and Education Act, with Oct